Projects funded by the NCN
Studies on activity and immunogenicity of baculovirus-expressed recombinant Plasmodium falciparum EBA-140 ligand binding region as a novel antimalarial vaccine candidate.
2012/05/N/NZ6/00667
Keywords:
Plasmodium falciparum EBA-140 antigen immunogenicity
Descriptors:
- NZ6_1: Adaptive and innate immunity
- NZ6_6: Parasitology
- NZ6_8: Other related subjects
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN
woj. dolnośląskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 3 - announced on 2012-03-15
Amount awarded: 100 000 PLN
Project start date (Y-m-d): 2013-02-21
Project end date (Y-m-d): 2016-02-20
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled